RADX logo

Radiopharm Theranostics Limited

RADX
Healthcare|Biotechnology|AU
$0.96
+0.07 (+7.85%)
Cash / Share
$0.35

Ownership Breakdown

63.6%
Float
1.3M
Shares Outstanding
0.8M
Float Shares

Major Holders (8)

Combined: 86.1%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
Lantheus Omega, LLCOther20.90%792,958,513Sep 4, 202613D/G
Lantheus Holdings, Inc.Corporation20.90%792,958,513Sep 4, 202613D/G
Lantheus Medical Imaging, Inc.Corporation17.30%792,958,513Sep 4, 202613D/G
Regal Partners Holdings Pty LimitedNon-US institution9.05%320,694,680Jan 8, 202613D/G
Regal Funds Management Pty LimitedNon-US institution7.30%172,634,988Jul 23, 202513D/G
Jpmorgan Chase & Co.Holding company4.00%145,679,951Jan 16, 202613D/G
Regal Partners Funds Management Pty LimitedNon-US institution3.34%157,139,443Oct 14, 202613D/G
Regal Partners LimitedNon-US institution3.34%157,139,443Oct 14, 202613D/G

Insider Trades (33)

Last 4 quarters: 20,591,333 acquired · 0 disposed
InsiderPositionDateTypeSharesPriceValueFiling
Voliotis DimitrisChief Medical OfficerOct 19, 2026AWARD10,295,667$0.02$216.2KForm 4
Voliotis DimitrisChief Medical OfficerOct 19, 2026AWARD10,295,666$0.02$216.2KForm 4
Voliotis DimitrisChief Medical OfficerJul 1, 2028OTHER7,657,334$0.03$191.4KForm 4
HOPPER PAULdirectorMar 18, 2026OTHER0——Form 4
HOPPER PAULdirectorMar 18, 2026OTHER0——Form 4
HOPPER PAULdirectorMar 18, 2026OTHER0——Form 4
HOPPER PAULdirectorJul 1, 2025OTHER1,403,723$0.17$238.6KForm 4
HOPPER PAULdirectorSep 13, 2024OTHER27,500,000$0.06$1.6MForm 4
HOPPER PAULdirectorJul 1, 2028OTHER6,048,542$0.03$151.2KForm 4
HOPPER PAULdirectorNov 25, 2022OTHER3,571,428$0.20$714.3KForm 4
Laurita Aaron JamesChief Financial OfficerMar 18, 2026OTHER0——Form 4
Laurita Aaron JamesChief Financial OfficerNov 25, 2022OTHER17,857$0.20$3.6KForm 4
Donnelly NoeldirectorMar 18, 2026OTHER5,333,333$0.06$320.0KForm 4
Turner Ian LawrencedirectorMar 18, 2026OTHER0——Form 4
Turner Ian LawrencedirectorMar 18, 2026OTHER0——Form 4
Turner Ian LawrencedirectorSep 12, 2024OTHER750,000$0.06$45.0KForm 4
Turner Ian LawrencedirectorMar 18, 2026OTHER6,814,000$0.03$170.3KForm 4
Turner Ian LawrencedirectorMar 18, 2026OTHER2,693,603$0.04$110.4KForm 4
Turner Ian LawrencedirectorMar 18, 2026OTHER483,768$0.11$54.2KForm 4
Turner Ian LawrencedirectorJul 1, 2025OTHER550,614$0.17$93.6KForm 4
Turner Ian LawrencedirectorNov 25, 2022OTHER70,422$0.20$14.1KForm 4
Canevari Riccardodirector, officer: Managing Director and CEOMar 18, 2026OTHER0——Form 4
Canevari Riccardodirector, officer: Managing Director and CEONov 25, 2022OTHER1,225,352$0.20$245.1KForm 4
Canevari Riccardodirector, officer: Managing Director and CEOJul 1, 2025OTHER12,000,000$0.06$720.0KForm 4
Canevari Riccardodirector, officer: Managing Director and CEONov 19, 2021OTHER8,666,678$0.60$5.2MForm 4
Canevari Riccardodirector, officer: Managing Director and CEOJul 1, 2025OTHER4,167,946$0.17$708.6KForm 4
Canevari Riccardodirector, officer: Managing Director and CEOMar 18, 2026OTHER2,476,127$0.11$277.3KForm 4
Canevari Riccardodirector, officer: Managing Director and CEOMar 18, 2026OTHER36,833,524$0.04$1.5MForm 4
Canevari Riccardodirector, officer: Managing Director and CEOMar 18, 2026OTHER74,338,000$0.03$1.9MForm 4
Larkin Hester DenisedirectorMar 18, 2026OTHER0——Form 4
Larkin Hester DenisedirectorMar 18, 2026OTHER5,333,333$0.06$320.0KForm 4
Larkin Hester DenisedirectorNov 16, 2024OTHER627,000$0.60$376.2KForm 4
Goodwin Bruce Michaeldirector: Mar 18, 2026OTHER0——Form 4